Seeking out a second opinion saved some cancer patients an average of $15,015, according to a study published Dec. 2 in JCO Oncology Practice.
For the study, researchers from New York City-based Memorial Sloan Kettering Cancer Center evaluated data from 120 patients who sought a second opinion after receiving a documented first opinion.
Here are five things to know from the study:
- Four cancer types — colorectal, head and neck, lung and myeloma — were represented by 30 patients each.
- Of the 120 patients, 43 had a change in treatment based on the second opinion.
- Of those 43 patients, 31 experienced lowered care costs after receiving the second opinion. Seven patients had increased care costs and five had no change to care costs.
- Average care cost savings ranged from $2,517 for lung cancer and $43,437 for myeloma.
- Cost savings were related to election of less-intensive surgeries or drug therapies, or shifting from treatment to observation.
Read the full study here.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
